Jul 14, 2016 - Teva Pharmaceutical (TEVA) will raise between $20B-$25B next week to finance its acquisition of Allergan's (AGN) generics business, Globes reports. The bon
Jul 13, 2016 - View slideshowTeva Pharmaceutical Industries Limited (NYSE:TEVA) 2016-2019 Preliminary Financial Outlook Conference July 13, 2016, 08:00 AM ET Executives Kevin C. Mannix - Senior Vice President of Inv
Jul 13, 2016 - On Wednesday, shares of Allergan (AGN) and Teva Pharmaceuticals (TEVA) are both on the rise, up around 2% and 3%, respectively, in morning trading after Teva CEO Erez Vigodman said it expects its $40.5 billion acquisition of Allergan's generics business to close any day.
Jul 13, 2016 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2016 Q2 earnings call.
Jul 13, 2016 - Teva's (TEVA) corporate presentation this morning has perked up investors. Shares are up 3% premarket on robust volume. CEO Erez Vigodman said that there a
Jul 13, 2016 - Ahead of its acquisition of Allergan's Generics business, Teva Pharmaceutical (TEVA) raised its second-quarter 2016 guidance for earnings and revenues.
May 30, 2016 - Many investors and analysts alike still have doubts over the impending Allergan deal. I still believe over the long term that it will turn out to be a success.Teva's forward price to earnings ratio lo
May 24, 2016 - Teva Pharma has had a tough go of it as of late.Regulatory hurdles and challenges to its existing commercial line-up have given investors a headache.Potential opportunities are running rampant with it
Apr 26, 2016 - John Keeley Comments on Teva Pharmaceuticals, Stocks: TEVA, John Keeley, release date:Apr 26, 2016
Apr 07, 2016 - Allergan's failed merger with Pfizer should set the table for its other mega-deal with Teva to close.Regulators no longer need to worry about ways to keep Pfizer in the US.Pfizer will probably spin of